Page last updated: 2024-08-24

venlafaxine hydrochloride and Sleep Wake Disorders

venlafaxine hydrochloride has been researched along with Sleep Wake Disorders in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bates, C; Burns, RB; Reynolds, EE; Richardson, M1
Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM1
Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, GJ; Keller, MB; Porta, G; Ryan, N; Shamseddeen, W; Wagner, KD1
Dragicevic, A; Grözinger, M; Härtter, S; Hiemke, C; Müller, MJ; Shams, M1
Klier, CM; Mossaheb, N; Saria, A; Schloegelhofer, M; Zernig, G1
Alvarez, E; Guilleminault, C; Lemoine, P1
Drucker-Colín, R; Galicia-Polo, L; Salín-Pascual, RJ1
Derivan, AT; Entsuah, R; Fabre, LF; Feighner, JP; Rickels, K; Rudolph, RL1
Guze, BH; Pierre, JM1
Riquier, F; Zullino, DF1

Trials

3 trial(s) available for venlafaxine hydrochloride and Sleep Wake Disorders

ArticleYear
Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
    Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:1

    Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Interactions; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sleep Wake Disorders; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride

2012
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.
    The Journal of clinical psychiatry, 2007, Volume: 68, Issue:11

    Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prevalence; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride

2007
A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:3

    Topics: Adult; Aged; Ambulatory Care; Anorexia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Placebos; Psychiatric Status Rating Scales; Sleep Wake Disorders; Treatment Outcome; Venlafaxine Hydrochloride

1998

Other Studies

7 other study(ies) available for venlafaxine hydrochloride and Sleep Wake Disorders

ArticleYear
Should This Patient Receive Hormone Therapy for Her Menopausal Symptoms?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Annals of internal medicine, 2018, 02-06, Volume: 168, Issue:3

    Topics: Antidepressive Agents, Second-Generation; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Quality of Life; Risk Assessment; Sleep Wake Disorders; Venlafaxine Hydrochloride

2018
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
    Menopause (New York, N.Y.), 2010, Volume: 17, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins

2010
Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.
    Pharmacopsychiatry, 2003, Volume: 36, Issue:1

    Topics: Adult; Aged; Antipsychotic Agents; Butyrophenones; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Methylation; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Venlafaxine Hydrochloride

2003
Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Dibenzothiazepines; Female; Humans; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy Trimesters; Quetiapine Fumarate; Sleep Wake Disorders; Trazodone; Venlafaxine Hydrochloride

2007
Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:8

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Male; Restless Legs Syndrome; Sleep; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Venlafaxine Hydrochloride

1997
Benztropine for venlafaxine-induced night sweats.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Benztropine; Borderline Personality Disorder; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Muscarinic Antagonists; Sleep Wake Disorders; Sweating; Venlafaxine Hydrochloride

2000
Venlafaxine and vivid dreaming.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:8

    Topics: Adult; Cyclohexanols; Dreams; Female; Humans; Sleep Wake Disorders; Somatoform Disorders; Venlafaxine Hydrochloride

2000